Nephrocare Heal.

Not Rated
  • Market Cap: N/A
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
461.80
-9.8 (-2.08%)
BSENSE

Dec 18

BSE+NSE Vol: 16.49 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
No of Months
12
12
12
12
Operating Income
755.00
566.00
437.00
317.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
Net Sales
755.00
566.00
437.00
317.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
Raw Materials Consumed
194.00
168.00
142.00
105.00
Power & Fuel Cost
20.00
14.00
13.00
9.00
Employee Cost
122.00
91.00
96.00
77.00
Operating Expenses
7.00
9.00
4.00
6.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
5.00
1.00
1.00
1.00
Cost of Software developments
0.00
0.00
0.00
0.00
Miscellaneous Expenses
18.00
20.00
99.00
82.00
Expenses Capitalised
0.00
0.00
0.00
0.00
Total Expenditure
589.00
465.00
388.00
300.00
Operating Profit (PBDIT) excl Other Income
166.00
100.00
48.00
16.00
Other Income
14.00
8.00
5.00
9.00
Operating Profit (PBDIT)
180.00
109.00
54.00
26.00
Interest
20.00
20.00
16.00
10.00
Profit before Depriciation and Tax
159.00
89.00
38.00
15.00
Depreciation
72.00
56.00
46.00
42.00
Profit Before Taxation & Exceptional Items
87.00
33.00
-8.00
-27.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
Profit Before Tax
87.00
33.00
-8.00
-27.00
Provision for Tax
20.00
-1.00
3.00
-5.00
Profit After Tax
67.00
35.00
-11.00
-21.00
Extraordinary Items
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
Profit Balance B/F
-96.00
-134.00
-121.00
-84.00
Profit Available for appropriations
-29.00
-99.00
-133.00
-105.00
Appropriations
-29.00
-99.00
-133.00
-105.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
8.28
4.55
-67.95
-130.96
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 33.50% vs 29.47% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 65.17% vs 107.61% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 3.25% vs 24.02% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 90.98% vs 398.02% in Mar 2024

Compare Profit and Loss Results of Nephrocare Heal.
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
755.00
0
755.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
755.00
0
755.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
194.00
0
194.00
0%
Power & Fuel Cost
20.00
0
20.00
0%
Employee Cost
122.00
0
122.00
0%
Operating Expenses
7.00
0
7.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
5.00
0
5.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
18.00
0
18.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
589.00
0
589.00
0%
Operating Profit (PBDIT) excl Other Income
166.00
0.00
166.00
0%
Other Income
14.00
0
14.00
0%
Operating Profit (PBDIT)
180.00
0
180.00
0%
Interest
20.00
0
20.00
0%
Profit before Depriciation and Tax
159.00
0
159.00
0%
Depreciation
72.00
0
72.00
0%
Profit Before Taxation & Exceptional Items
87.00
0
87.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
87.00
0
87.00
0%
Provision for Tax
20.00
0
20.00
0%
Profit After Tax
67.00
0
67.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
-96.00
0
-96.00
0%
Profit Available for appropriations
-29.00
0
-29.00
0%
Appropriations
-29.00
0
-29.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
8.28
0
8.28
0%
Profit And Loss - Net Sales
Net Sales 755.81 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 33.50% vs 29.47% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 166.64 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 65.17% vs 107.61% in Mar 2024

Profit And Loss - Interest
Interest 20.83 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 3.25% vs 24.02% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 67.10 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 90.98% vs 398.02% in Mar 2024